Le Lézard1h
First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...
Too Old to Operate6h
Comparing Treatments for LUTS After BCG Immunotherapy
The following is a summary of “Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy ...
Targeted Oncology6d
FDA Grants Key Oncology Approvals and Designations in January 2025
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
BioSpace9d
Pfizer Sees Path to Braftovi’s Full Approval With Phase III CRC Data
Topline data on a combo including Pfizer’s kinase inhibitor Braftovi point to improved progression-free survival and pave the ...
Hockey Feed15d
GM Bill Guerin confirms that Kaprizov will be out long-term following surgery
UPDATE: Bill Guerin has confirmed that superstar forward Kirill Kaprizov will indeed undergo surgery for a lower body and will be out of the team's lineup for at least four weeks. While Guerin ...
Yahoo Finance21d
Game-Changing Cancer Breakthroughs: What to Watch in 2025
Research and Markets projects the cancer immunotherapy market alone to be valued at US ... an investigational anti-PD-1 monoclonal antibody (mAB), in combination with Bacillus Calmette-Guérin (BCG) as ...
ImmunityBio, Inc. (IBRX) Stock: An Under $5 Gem with Biggest Upside Potential
We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against other stocks ...
Insider Monkey22d
ImmunityBio, Inc. (IBRX) Stock: An Under $5 Gem with Biggest Upside Potential
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company developing ... of bladder cancer in combination with BCG (Bacillus Calmette-Guérin). The company has implemented a ...
urologytimes22d
United in Choice: The Critical Role of Shared Decision-Making for Patients with Bladder Cancer
Ashish M. Kamat, MD, MBBS, provides expert insights into the current state of bladder cancer care, emphasizing the critical role of patient-centric approaches and exploring the evolving treatment ...
Insider Monkey23d
12 Stocks Under $5 With Biggest Upside Potential
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company developing ... of bladder cancer in combination with BCG (Bacillus Calmette-Guérin). The company has implemented a ...
Asia News Network23d
Two ‘off-label’ chemo drugs used together to fight bladder cancer successfully in Singapore
The most common immunotherapy for treating early-stage bladder cancer is the Bacillus Calmette-Guerin (BCG) vaccine treatment. If that fails, the only other alternative is surgery to remove the entire ...
The Straits Times26d
Two ‘off-label’ chemo drugs used together to fight bladder cancer successfully in Singapore
The most common immunotherapy for treating early-stage bladder cancer is the Bacillus Calmette-Guerin (BCG) vaccine treatment. If that fails, the only other alternative is surgery to remove the ...